Evidence map›Paper›PMID 33335840›Full record

ArticleMolecular genetics and metabolism reports2020

Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers.

Mousumi Bose, David D Cuthbertson, Marsha A Fraser, Jean-Baptiste Roullet, K Michael Gibson, Dana R Schules, Kelly M Gawron, Melissa B Gamble, Kathryn M Sacra, Melisa J Lopez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics and metabolism reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Polyunsaturated fatty acid metabolism in the retinal pigment epithelium and its association with outer retinal disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Mousumi BoseDepartment of Nutrition and Food Stsudies, Montclair State University, 1 Normal Avenue, UN 2159, Montclair, NJ 07043, USA.
David D CuthbertsonDepartment of Health Informatics Institute, College of Medicine Pediatrics, University of South Florida, 4202 E Fowler Ave, Tampa, FL 33620, USA.
Marsha A FraserDepartment of Health Informatics Institute, College of Medicine Pediatrics, University of South Florida, 4202 E Fowler Ave, Tampa, FL 33620, USA.
Jean-Baptiste RoulletDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, 412 E. Spokane Falls Blvd, Spokane, WA 99210, USA.
K Michael GibsonDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, 412 E. Spokane Falls Blvd, Spokane, WA 99210, USA.
Dana R SchulesDepartment of Nutrition and Food Stsudies, Montclair State University, 1 Normal Avenue, UN 2159, Montclair, NJ 07043, USA.
Kelly M GawronDepartment of Nutrition and Food Stsudies, Montclair State University, 1 Normal Avenue, UN 2159, Montclair, NJ 07043, USA.
Melissa B GambleGlobal Foundation for Peroxisomal Disorders, P.O. Box 33238, Tulsa, OK 74153, USA.
Kathryn M SacraGlobal Foundation for Peroxisomal Disorders, P.O. Box 33238, Tulsa, OK 74153, USA.
Melisa J LopezGlobal Foundation for Peroxisomal Disorders, P.O. Box 33238, Tulsa, OK 74153, USA.
William B RizzoDepartment of Pediatrics, University of Nebraska Medical Center University of Nebraska, 985940 Nebraska Medical Center - DRC II 4064, Omaha, NE 68198-5940, USA.
Montclair State University · USUniversity of South Florida · USWashington State University Spokane · USUniversity of Nebraska Medical Center · US

Funding

Sterol and Isoprenoid Diseases Consortium Supplement 2018U54HD061939 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GAHL, WILLIAM ALLEN · 2009 to 2018
$6.6M
NICHD NIH HHS U54 HD061939
6 · The paper itself

Abstract

Zellweger spectrum disorders (ZSD) are rare, debilitating genetic diseases of peroxisome biogenesis that affect multiple organ systems and present with broad clinical heterogeneity. Although many case studies have characterized the multitude of signs and symptoms associated with ZSD, there are few reports on the prevalence of symptoms to help inform the development of meaningful endpoints for future clinical trials in ZSD. In the present study, we used an online survey tool completed by family caregivers to study the occurrence, frequency and severity of symptoms in individuals diagnosed with ZSD. Responses from caregivers representing 54 living and 25 deceased individuals with ZSD were collected over an 8-month period. Both perception of disease severity and prevalence of various symptoms were greater in responses from family caregivers of deceased individuals compared to those of living individuals with ZSD. Compared with previous reports for ZSD, the combined prevalence of seizures (53%) and adrenal insufficiency (45%) were nearly twice as high. Overall, this community-engaged approach to rare disease data collection is the largest study reporting on the prevalence of symptoms in ZSD, and our findings suggest that previous reports may be underreporting the true prevalence of several symptoms in ZSD. Studies such as this used in conjunction with clinician- led reports may be useful for informing the design of future clinical trials addressing ZSD.

Indexed as

Caregiver reportCross-sectional studyDMCC, Data Management and Coordinating CenterDXA, dual-energy x-ray absorptiometryEEG, ElectroencephalogramGFPD, Global Foundation for Peroxisomal DisordersMRI, Magnetic Resonance ImagingPBDs, Peroxisome biogenesis disordersPeroxisome biogenesis disorderRare diseaseRDCRN, Rare Diseases Clinical Research NetworkSTAIR, Sterol and Isoprenoid Research ConsortiumSurveys and questionnairesSymptom prevalenceZellweger spectrum disordersZSD, Zellweger Spectrum Disorder

Identifiers

PMID33335840
PMCPMC7733019
OpenAlexW3111099682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.